Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08EYN
|
|||
| Drug Name |
Acrylamide compound 2
|
|||
| Synonyms |
PMID29334795-Compound-51A
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
SUVEN LIFE SCIENCES LIMITED
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H30N2O3
|
|||
| Canonical SMILES |
C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)C=CC(=O)N4CCOCC4
|
|||
| InChI |
1S/C22H30N2O3/c25-22(24-14-16-26-17-15-24)9-6-18-4-7-20(8-5-18)27-21-10-12-23(13-11-21)19-2-1-3-19/h4-9,19,21H,1-3,10-17H2/b9-6+
|
|||
| InChIKey |
MXFWFZGVHOHBHI-RMKNXTFCSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine H3 receptor (H3R) | Target Info | . | [1] |
| Target's Patent Info | Histamine H3 receptor (H3R) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Histamine receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | Monoamine Transport | |||
| GPCRs, Class A Rhodopsin-like | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017).Expert Opin Ther Pat. 2018 Mar;28(3):175-196. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.